We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Joint CMS-FDA Comparative Effectiveness Initiative in Jeopardy
Joint CMS-FDA Comparative Effectiveness Initiative in Jeopardy
October 6, 2006
The future of the Centers for Medicare & Medicaid Services’ (CMS) plan to share prescription drug plan data with the FDA in an effort to base Medicare reimbursement on product comparisons is in doubt as the agency determines whether it has the legal authority to share this information, an industry source says.